Gibson, A., Nunez, C., Robusto, L., Kammerer, B., Garcia, M., Roth, M., Sheth, R., Tewari, P., Hittle, A., Toepfer, L., Torres, R., Short, N. J., Jabbour, E., Jain, N., Cuglievan, B. and McCall, D. (2020) “Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.284950.